Kaynaklar
- Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. CMAJ 2003; 168(11): 1439–42.
- Özdemir S, Kocabaşoğlu N. Serotonin sendromuna güncel bir yaklaşım. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2007; 17(4): 217–25.
- Montane E, Barriocanal A, Isern I, Parajon T, Costa J. Multiple drug interactions induced serotonin syndrome: a case report. J Clin Pharm Ther 2009; 34(4): 485–7
- Ailawadhi S, Sung KW, Carlson LA, Baer MR. Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 2007; 32(2): 199–202.
- Trivedi MH, Desaiah D, Ossana MJ, Pritchett YL, Brannan SK, Detke MJ. Clinical evidence for serotonin and norepinefrine reuptake inhibition of duloxetine Int Clin Psychopharmacol 2008; 23(3): 161–9.
- Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705–13.
- Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter serotonin toxicity criteria: simple and accurate diagnositic decision rules for serotonin toxicity. QJM 2003; 96(9): 635–42
- Radomski JW, Dursun SM, Reveley MA, Kutcher SP. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnositic criteria. Med Hypotheses 2000: 55: 218–24.
- Hadikusumo B, Ng B. Serotonin syndrome induced by duloxetine. Aust N Z J Psychiatry. 2009; 43(6): 581–2.
- Gelener P, Gorgulu U, Kutlu G, Ucler S, Inan LE. Serotonin syndrome due to duloxetine. Clin Neuropharmacol 2011; 34(3): 127–8.
- Brouwers EE, Söhne M, Kuipers S, van Gorp EC, Schellens JH, Koks CH et al. Ciprofloxacin strongly inhibits clozapine metabolism: two case reports. Clin Drug Investig 2009; 29(1): 59–63
- Knadler MP, Lobo E, Chappell J, Bergstrom R. Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet 2011; 50(5): 281–94
- Lee J, Franz L, Goforth HW. Serotonin syndrome in a chronic pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine. Psychosomatics 2009; 50(6): 63